Illumina (ILMN) Convertible Debt (2011 - 2022)

Illumina (ILMN) reported Convertible Debt of $746.0 million for Q2 2022, up 9.71% on a YoY basis from $680.0 million in Q2 2021, and up 6.27% quarter-over-quarter from $702.0 million in Q1 2022.

Illumina (ILMN) Convertible Debt (2011 - 2022) Analysis & Trends

Illumina has reported Convertible Debt for 7 years, with the latest figure at $746.0 million in Q2 2022.

  • For the quarter ending Q2 2022, Convertible Debt rose 9.71% year-over-year to $746.0 million; the trailing twelve-month figure through Apr 2022 stood at $746.0 million (up 9.71% YoY), and the FY2022 full-year result was $702.0 million, up 4.31% from the prior year.
  • Convertible Debt for Q2 2022 stood at $746.0 million, up from $702.0 million in the prior quarter.
  • The five-year high for Convertible Debt was $746.0 million in Q2 2022, with the low at $673.0 million in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 29,902.70 Bn 29,902.24 Bn 1.11 Bn
2 Thermo Fisher Scientific 175.99 Bn 172.74 Bn 7.74 Bn
3 Danaher 129.87 Bn 124.18 Bn 3.59 Bn
4 Idexx Laboratories 44.75 Bn 44.55 Bn 722.74 Mn
5 Agilent Technologies 37.52 Bn 35.72 Bn 990.00 Mn
6 Iqvia Holdings 30.91 Bn 28.94 Bn 1.36 Bn
7 Natera 30.21 Bn 29.11 Bn 696.04 Mn
8 Illumina 24.19 Bn 23.04 Bn 721.00 Mn
9 Mettler Toledo International 23.12 Bn 23.06 Bn 555.82 Mn
10 Quest Diagnostics 21.68 Bn 21.59 Bn 942.00 Mn

Historic Data

Download Data
DateValue
Apr 3, 2022 746.00 Mn
Jan 2, 2022 702.00 Mn
Oct 3, 2021 694.00 Mn
Jul 4, 2021 687.00 Mn
Apr 4, 2021 680.00 Mn
Jan 3, 2021 673.00 Mn
Jun 28, 2015 1.00 Bn
Mar 29, 2015 993.78 Mn
Dec 28, 2014 986.78 Mn
Sep 28, 2014 979.84 Mn
Jun 29, 2014 972.95 Mn
Dec 29, 2013 839.31 Mn
Sep 29, 2013 830.69 Mn
Jun 30, 2013 822.17 Mn
Mar 31, 2013 813.74 Mn
Dec 30, 2012 805.41 Mn
Sep 30, 2012 797.16 Mn
Jul 1, 2012 789.01 Mn
Apr 1, 2012 780.94 Mn
Jan 1, 2012 807.37 Mn